Advertisement

Topics

Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two ...

08:30 EST 10 Nov 2017 | BioMedReports - Blog

TEL AVIV, Israel, Nov. 10, 2017/PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of

Read more...

Original Article: Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two ...

NEXT ARTICLE

More From BioPortfolio on "Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two ..."

Advertisement
Quick Search
Advertisement
Advertisement